Volitionrx (VNRX) Gross Profit (2019 - 2025)

Volitionrx has reported Gross Profit for 7 years, with the latest figure at -$1.0 million in Q4 2025.

• For the quarter ending Q4 2025, Gross Profit rose 21.95% year-over-year to -$1.0 million; the trailing twelve-month figure through Dec 2025 stood at -$2.7 million (up 38.26% YoY), and the FY2025 full-year result was -$2.6 million, up 39.33% from the prior year.
• Gross Profit for Q4 2025 stood at -$1.0 million, down from -$420186.0 in the prior quarter.
• The five-year high for Gross Profit was -$401871.0 in Q1 2021, with the low at -$1.8 million in Q4 2021.
• Historically, Gross Profit has averaged -$1.2 million across 5 years, with a median of -$1.3 million in 2023.
• Annual changes were most pronounced in 2021 — Gross Profit plunged 443.25% — and 2025, when it surged 55.31%.
• Volitionrx's Gross Profit stood at -$1.8 million in 2021, then grew by 13.56% to -$1.6 million in 2022, then fell by 6.19% to -$1.7 million in 2023, then grew by 22.16% to -$1.3 million in 2024, then climbed by 21.95% to -$1.0 million in 2025.
• The last three Gross Profit figures came in at -$1.0 million (Q4 2025), -$420186.0 (Q3 2025), and -$636846.0 (Q2 2025), per Business Quant data.